This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: **Brijendra Kumar Tripathi: A Pioneer in Pharmaceutical Innovations**
Introduction
Brijendra Kumar Tripathi, based in Lucknow, India, is a notable inventor whose work in the field of pharmaceuticals has garnered attention. He has been recognized for his innovative contributions to medical treatments, particularly his endeavors in combatting diabetes and dyslipidemia.
Latest Patents
Tripathi holds a significant patent for a pharmaceutical composition aimed at the treatment of diabetes and dyslipidemia. His patent involves a bioactive fraction that has shown effectiveness as both an antidiabetic and antidyslipidemic agent. The focus of this invention is the preparation of isomeric xyloccensins and related pharmaceutical compositions. These compositions may include a therapeutically effective amount of isomeric xyloccensins, combined with various pharmaceutically acceptable carriers, additives, lubricants, and diluents to enhance their efficacy in treating dyslipidemia.
Career Highlights
Throughout his career, Brijendra Kumar Tripathi has been affiliated with the Council of Scientific & Industrial Research (CSIR), where he has dedicated his efforts to pioneering research in pharmaceutical sciences. His commitment to innovation is evident in his contributions to developing effective treatments that address significant health concerns.
Collaborations
In his journey as an inventor, Tripathi has collaborated with esteemed colleagues such as Vijai Lakshmi and Ajet Saxena. These collaborations have provided a strong foundation for his research, facilitating advancements in the pharmaceutical field and enhancing the impact of his inventions.
Conclusion
Brijendra Kumar Tripathi exemplifies the spirit of innovation within the pharmaceutical industry. His patent for a bioactive fraction represents a significant step forward in treating diabetes and dyslipidemia, showcasing the potential of scientific research to improve health outcomes. As he continues his work with the Council of Scientific & Industrial Research, the contributions of this talented inventor will undoubtedly lead to further advancements in medical treatments.